The Louis-Jeantet Foundation has announced that its 2019 prizes have been awarded to Luigi Naldini, Director of the San Raffaele Telethon Institute for Gene Therapy and Professor at the San Raffaele University in Milan, Italy, and to Botond Roska, a founding director of the Institute of Molecular and Clinical Ophthalmology Basel in Switzerland.
Naldini has been bestowed with the Prize for Translational Medicine for his pioneering work that took gene therapy from the bench to the bedside.
Roska has been awarded the Prize for Medicine for the discovery of basic principles of visual information processing and the development of therapeutic strategies, such as gene therapy, to restore vision in retinal disorders.
The Louis-Jeantet Foundation will grant both winners in the region with €440,000, of which just under €400,000 is for the continuation of the prize-winner’s research, whereas the remainder is for personal use.
Since first established in 1986, the Louis-Jeantet Foundation has recognised 90 leading-edge researchers in Member States of the Council of Europe, of which 12 have subsequently been awarded the Nobel Prize in Physiology or Medicine or the Nobel Prize in Chemistry.